{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:58:49Z","timestamp":1761058729730},"reference-count":12,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T00:00:00Z","timestamp":1191888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Artificial Organs"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Sevelamer hydrochloride (HCl) contains multiple amines that may cause a significant dietary acid load. To evaluate the impact of sevelamer on arterial blood gases, we followed two groups of stable hemodialysis patients for 24\u2003months. The Sevelamer Group (<jats:italic>n<\/jats:italic>\u2003=\u20037) did not achieve the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K\/DOQI) goals for phosporus and Ca\u2003\u00d7\u2003P product and was switched from a calcium\u2010based to sevelamer\u2010based regimen. The Calcium Group (<jats:italic>n<\/jats:italic>\u2003=\u20037) achieved those goals and remained on calcium salts. Following sevelamer administration, a deterioration of chronic metabolic acidosis was revealed, which lasted throughout the study. Sevelamer therapy was associated with reduced cholesterol levels, improved serum phosphate, and Ca\u2003\u00d7\u2003P product, which facilitated the management of secondary hyperparathyroidism. No significant changes in acid\u2013base status or other parameter tested were found in the Control Group. In conclusion, sevelamer intake caused small but persistent acid\u2013base disturbances, which did not neutralize sevelamer's beneficial effects on mineral and lipid metabolism.<\/jats:p>","DOI":"10.1111\/j.1525-1594.2007.00484.x","type":"journal-article","created":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T08:19:27Z","timestamp":1191917967000},"page":"892-895","source":"Crossref","is-referenced-by-count":7,"title":["Chronic Acid\u2013Base Perturbations in Hemodialysis Patients Treated with Sevelamer Hydrochloride: A Two\u2010year Follow\u2010up Study"],"prefix":"10.1111","volume":"31","author":[{"given":"Demetrios V.","family":"Vlahakos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi","family":"Retsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Kalogeropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spiros","family":"Katsoudas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Bacharaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basil","family":"Agroyannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,10,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl395"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90009-3"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP62104"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.12.2907"},{"issue":"90","key":"e_1_2_6_6_2","first-page":"S39\u2013S45","article-title":"Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implications","volume":"66","author":"Brezina B","year":"2004","journal-title":"Kidney Int"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063307"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00590.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.3.582"},{"issue":"9","key":"e_1_2_6_10_2","first-page":"S108\u201314","article-title":"Sevelamer worsens metabolic acidosis in hemodialysis patients","volume":"19","author":"De Santo NG","year":"2006","journal-title":"J Nephrol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.2002.06883.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2006.00544.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-200048238"}],"container-title":["Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1594.2007.00484.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-1594.2007.00484.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T11:13:48Z","timestamp":1697109228000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-1594.2007.00484.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,9]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1525-1594.2007.00484.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1594.2007.00484.x","archive":["Portico"],"relation":{},"ISSN":["0160-564X","1525-1594"],"issn-type":[{"value":"0160-564X","type":"print"},{"value":"1525-1594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,9]]}}}